Join us online on April 29th at 12pm EDT to learn all about BioCentriq, a state of the art cell and gene therapy process development and clinical manufacturing center located in New Jersey.During this session …

A 4-day online virtual training course in upstream and downstream processing of viral vectors used in cell and gene therapy. The course will focus on viral vector theory, technical demonstrations of bioreactors, demonstration of chromatography, …

NJII’s Biopharma Division will be presenting at the Alliance for Regenerative Medicine’s Meeting on the Mediterranean annual conference. If you are interested in getting in touch with them, contact us.

Please join Joseph Tarnowski, SVP, Cell & Gene Therapy, R&D Medicinal Science and Technology at GSK, Hari Pujar, Ph.D., Operating Partner at Flagship Pioneering, Haro Hartounian, Ph.D., SVP & General Manager, BioCentriq and Michael Lehmicke, …

A 4-day online virtual training course in upstream and downstream processing of viral vectors used in cell and gene therapy. The course will focus on viral vector theory, technical demonstrations of bioreactors, demonstration of chromatography, …

Haro Hartounian, head of our biopharma division, will be leading a panel discussion with leaders from Cytiva, GlaxoSmithKline, Amicus Therapeutics and Legend BioTech on the future of Cell & Gene Therapy Manufacturing. We will also …

Choose New Jersey is hosting the first of what they plan to be a series of live webinars entitled “New Jersey: A Rising Cell & Gene Therapy Hub.” The first session will be a virtual …

Alex Klarer, Head of Cell Therapy Development at BioCentriq will be speaking.

A 4-day online virtual training course in upstream and downstream processing of viral vectors used in cell and gene therapy. The course will focus on viral vector theory, technical demonstrations of bioreactors, demonstration of chromatography, …

Meet with members of the NJII Biopharma team at this online event where world renowned leaders share the latest analytical techniques & vector technologies.